HG Ventures recently participated in a $16M funding round for Massachusetts startup, Aclarity, a company focused on the destruction of PFAS. The investment expands our portfolio of water startups, and here, senior director Ginger Rothrock outlines our investment rationale.
HG Ventures’ Nick Arnold recently attended the Cleantech Forum North America, which brings together leaders in the sustainable innovation ecosystem – start-ups, scale-ups, investors, corporates, government and more. Here, Nick shares his observations and insights from the three-day event.
HG Ventures participated in INERATEC’s Series B round, alongside Piva Capital and other investors. INERATEC is developing e-fuels and e-chemicals by recycling CO2 with renewable energy.
As we begin 2024, HG Ventures’ Jon Schalliol looks back on a tumultuous year for venture capital and sustainability tech investment, the strategic investments the firm has made, and other highlights.
HG Ventures’ portfolio company, Vartega, Secures $10M in Equity Financing Led by Diamond Edge Ventures to Promote Fenix Fiber™ EasyFeed Bundles™ for Applications in Automotive, Additive Manufacturing, Consumer Electronics, and Sporting Goods.
HG Ventures’ portfolio company, Aclarity, has been honored as the 2023 Company of the Year by Frost & Sullivan for its outstanding contributions to the North American PFAS treatment industry.
HG Ventures’ portfolio company, Currents, launched their marketplace with battery inventory eligible for a second-life, and one of the first users of the platform is Nissan North America.
The following post is an excerpt from HG Ventures’ Future of Roads Report (November 2023) – An Introduction by John Glushik.
New report from HG Ventures calls for an expanded role for technology innovators in creating ‘smarter’ roads.
Aclarity, Inc., the leader in PFAS (Per- and Polyfluoroalkyl Substances) “forever chemical” destruction, announced today the successful completion of its $15.9 million Series A funding round, with participation from HG Ventures.
In August 2023, HG Ventures led a €10M investment round in German biotech company, Bind-X. Here, Nick Arnold details the rationale, and why this is such a strong fit for our portfolio.
HG Ventures recently increased its investment in Puraffinity, participating in the London-based startup’s $13.9M Series A funding round. Puraffinity is focused on combating the ‘forever chemicals’ found in water; here, Co-founder and CEO Henrik Hagemann shares his insights from participating in this year’s United Nations Water Conference, and his ambitions for the future.